Park M, Kitchener H, Macnab J
EMBO J. 1983; 2(7):1029-34.
PMID: 6313349
PMC: 555230.
DOI: 10.1002/j.1460-2075.1983.tb01541.x.
Woodman C, Stocker D, Sugrue D, Desberbasques M, Hartley C, Fuller A
Med Microbiol Immunol. 1983; 171(4):243-50.
PMID: 6304481
DOI: 10.1007/BF02123498.
Skinner G, Woodman C, Hartley C, Buchan A, Fuller A, Durham J
Br J Vener Dis. 1982; 58(6):381-6.
PMID: 6293640
PMC: 1046107.
DOI: 10.1136/sti.58.6.381.
McDougall J, Crum C, Fenoglio C, Goldstein L, Galloway D
Proc Natl Acad Sci U S A. 1982; 79(12):3853-7.
PMID: 6285365
PMC: 346526.
DOI: 10.1073/pnas.79.12.3853.
Skinner G, Buchan A, Hartley C, Turner S, Williams D
Med Microbiol Immunol. 1980; 169(1):39-51.
PMID: 6258035
DOI: 10.1007/BF02123711.
Prepubertal vaccination of mice against experimental infection of the genital tract with type 2 herpes simplex virus.
Skinner G, Williams D, Moles A, Sargent A
Arch Virol. 1980; 64(4):329-38.
PMID: 6249243
PMC: 7101888.
DOI: 10.1007/BF01320618.
Cellular proteins expressed in herpes simplex virus transformed cells also accumulate on herpes simplex virus infection.
Macnab J, Orr A, La Thangue N
EMBO J. 1985; 4(12):3223-8.
PMID: 3004943
PMC: 554646.
DOI: 10.1002/j.1460-2075.1985.tb04069.x.
Augmentation of the neutralisation test for type 1 HSV: evidence of high representation of neutralising antibody in the adult community.
Holmes P, Hallworth J, Stocker D, Skinner G
Med Microbiol Immunol. 1985; 174(4):167-75.
PMID: 2999572
DOI: 10.1007/BF02123693.
Neutralising antibody against type 1 and type 2 herpes simplex virus in cervical mucus of women with cervical intra-epithelial neoplasia.
Murphy J, Murphy D, Barker S, Mylotte M, Coughlan B, Skinner G
Med Microbiol Immunol. 1985; 174(2):73-80.
PMID: 2993833
DOI: 10.1007/BF02123228.
Preparation and efficacy of an inactivated subunit vaccine (NFUIBHK) against type 2 Herpes simplex virus infection.
Skinner G, Williams D, Buchan A, Whitney J, Harding M, Bodfish K
Med Microbiol Immunol. 1978; 166(1-4):119-32.
PMID: 214676
DOI: 10.1007/BF02121141.
Prevalence of type-specific antibody against type 1 and type 2 herpes simplex virus in women with abnormal cervical cytology: evidence towards pre-pubertal vaccination of sero-negative female subjects.
Skinner G, WHITNEY J, Hartley C
Arch Virol. 1977; 54(3):211-21.
PMID: 196578
DOI: 10.1007/BF01314787.
Transformation of primary hamster embryo fibroblasts by type 2 simplex virus: evidence for a "hit and run" mechanism.
Skinner G
Br J Exp Pathol. 1976; 57(4):361-76.
PMID: 183803
PMC: 2041152.
Detection of type-specific antibody to herpes simplex virus type 1 and 2 in human sera by complement-fixation tests.
Skinner G, Hartley C, WHITNEY J
Arch Virol. 1976; 50(4):323-33.
PMID: 179502
DOI: 10.1007/BF01317957.
